找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management; Aamir Ahmad,Shirish M. Gadgeel Book 2016 The Editor(s) (if

[复制链接]
楼主: 欺骗某人
发表于 2025-3-23 09:59:11 | 显示全部楼层
发表于 2025-3-23 14:14:35 | 显示全部楼层
发表于 2025-3-23 18:38:46 | 显示全部楼层
发表于 2025-3-23 22:20:54 | 显示全部楼层
发表于 2025-3-24 03:26:13 | 显示全部楼层
Personalized Therapy of Small Cell Lung Cancer,acteristics. Despite robust responses to initial chemotherapy and radiation, the prognosis of patients with SCLC remains poor with an overall 5-year survival rate of less than 10 %. Despite the fact that numerous molecularly targeted approaches have thus far failed to demonstrate clinical utility in
发表于 2025-3-24 06:48:26 | 显示全部楼层
发表于 2025-3-24 12:20:17 | 显示全部楼层
发表于 2025-3-24 18:12:23 | 显示全部楼层
https://doi.org/10.1007/978-3-319-24932-2Lung cancer; Genomics; Therapeutic Implications; Stem Cells; Small Cell Lung Cancer; Radiation Therapy
发表于 2025-3-24 20:12:25 | 显示全部楼层
978-3-319-79702-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
发表于 2025-3-25 01:50:15 | 显示全部楼层
Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management978-3-319-24932-2Series ISSN 0065-2598 Series E-ISSN 2214-8019
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-23 02:06
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表